Log In Get Started
Press Releases July 23, 2026 05:00 PM

embecta to Report Fiscal Third Quarter Financial Results

Embecta Announces Date for Fiscal Q3 2026 Financial Results Conference Call

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
EMBC

Embecta Corp., a global medical supplies company with a legacy in insulin delivery, will report its fiscal third quarter 2026 financial results via a conference call on August 7, 2026. The event includes an operational update and Q&A session, accessible through webcast and teleconference. A replay will be available for one year on the company's investor website.

embecta to Report Fiscal Third Quarter Financial Results
EMBC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Embecta will release its fiscal Q3 2026 financial results on August 7, 2026.
  • The company will provide an operational update and host a live Q&A session during the conference call.
  • Embecta is transitioning from insulin delivery to becoming a broad-based medical supplies company, impacting the healthcare equipment sector.

PARSIPPANY, N.J., July 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 7, 2026.

Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.

A webcast replay of the call will be available beginning at 11:00 a.m. ET on August 7, 2026, via the embecta investor relations website and archived on the website for one year.

About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:   MediaInvestorsChristian GlazarPravesh KhandelwalSr. Director, Corporate CommunicationsVP, Head of Investor Relations908-821-6922551-264-6547Contact Media RelationsContact IR

Risks

  • Financial performance uncertainty until the fiscal Q3 results are released affecting investor sentiment in healthcare and medical supplies sectors.
  • The transition phase to a broader medical supplies company may involve execution risks impacting growth and profitability.
  • Market and regulatory challenges inherent in the global healthcare supplies industry could affect future operational outcomes.

More from Press Releases

NVIDIA and KAIST Launch Joint AI Research Lab to Accelerate AI Innovation in Korea Jul 23, 2026 Pelican Acquisition II Corporation Announces Pricing of $75,000,000 Initial Public Offering Jul 23, 2026 Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2027 First Quarter Earnings Release and Conference Call Webcast Jul 23, 2026 ATN International to Host Second Quarter 2026 Financial Results Conference Call on August 6, 2026 Jul 23, 2026 Market Technology Acquisition Corp Announces the Pricing of $200 Million Initial Public Offering Jul 23, 2026